ARTICLE | Politics & Policy
CIRM, Quintiles to create stem cell center
June 17, 2016 12:32 AM UTC
The California Institute for Regenerative Medicine said it will invest $15 million to launch a stem cell Accelerating Center in partnership with Quintiles Transnational Holdings Inc. (NYSE:Q). CIRM said the center will provide regulatory and operational support for clinical trials, as well as data management, biostatistical, analytical and management services.
CIRM spokesperson Kevin McCormack told BioCentury that Quintiles will run the center after CIRM's initial investment. ...